An Open-Label, Sequential Design Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Ibrutinib in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 22 Mar 2014
At a glance
- Drugs Ibrutinib (Primary) ; Ketoconazole
- Indications Chronic lymphocytic leukaemia; Diffuse large B cell lymphoma; Mantle-cell lymphoma; Multiple myeloma
- Focus Pharmacokinetics
- 27 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Jul 2012 New trial record